Batch worksheet: Aprepitant 20 mg/mL from 80 mg capsules — source discrepancy
CGR-FR-030 · Blank fields for controlled execution
DO NOT COMPOUND — unresolved source inconsistency.
COMPOUNDING ON HOLD: an unresolved critical discrepancy exists. This record is for study and investigation; do not execute until a documented resolution is available.
Aprepitant: monograph uses 4 × 80 mg; the 80 mg technical note (18/05/2026, p.2) method says 4 × 125 mg. Do not compound pending publisher clarification. The 16 mL is added vehicle, not q.s. ad.
Aprepitant: monograph uses 4 × 80 mg; the 80 mg technical note (18/05/2026, p.2) method says 4 × 125 mg. Do not compound pending publisher clarification. The 16 mL is added vehicle, not q.s. ad.
Companion batch worksheet. Use with the full monograph and a locally approved master record. This is not a standalone recipe. Complete by hand after printing.
CGR-FR-030 · Monograph 4.0 · Web 4.0 · 10.09.2026
| Local master ID / version | Batch / date |
|---|---|
Materials and actual quantities
| Material | Source | Local target | Actual amount | Lot / expiry / check |
|---|---|---|---|---|
| Aprepitant 80 mg capsules | 4 καψάκια / capsules | |||
| Ora-Blend OR Ora-Blend SF | 16 mL ΠΡΟΣΘΗΚΗ / ADDED |